FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug
Summary
FDA is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol ...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.